New drug LYT-200 tested in patients with relapsed blood cancers
NCT ID NCT05829226
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This early-stage study tested a new drug called LYT-200 in 101 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had returned or stopped responding to treatment. The main goal was to check the drug's safety and find the right dose. Researchers also looked for signs that the drug might help control the cancer, but this is not a cure and ongoing management is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML, ADULT RECURRENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baptist Health South Florida-Miami Cancer Institute
Miami, Florida, 02114, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Mass. General Hospital-Harvard
Boston, Massachusetts, 02114, United States
-
Norton Healthcare-Norton Cancer Institute
Louisville, Kentucky, 40207, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08901, United States
-
University of California Irvine Medical Center
Orange, California, 92868, United States
-
Virginia Commonwealth University Medical Center
Richmond, Virginia, 23219, United States
Conditions
Explore the condition pages connected to this study.